Hledání v detailu akcií
Top akcie
NázevNávštěvy
19 188
879
854
807
610
539
528
384
378
374
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ5525530,36
KB916916,5-0,22
PKN80,7280,76-1,56
Msft99,9899,99-0,86
Nokia5,0985,104-0,97
IBM143,81143,83-0,48
DCX60,6460,65-1,77
PFE36,0636,07-0,28
19.6.2018 16:11:54
Indexy online
AD Index online
select
AD Index online
 

  • 19.6.2018 16:06:26
Inogen (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
187,71 -1,35 -2,56 13 019
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.6.2018
Popis společnosti
Obecné informace
Název společnostiInogen Inc
TickerINGN
Kmenové akcie:Ordinary Shares
RICINGN.O
ISINUS45780L1044
Poslední známé roční výsledky31.12.2017
Poslední známé čtvrtletní výsledky31.3.2018
Počet zaměstnanců k 31.12.2017 770
Akcie v oběhu k 20.4.2018 21 220 517
Počet akcionářů k 31.12.2017 16
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice326 Bollay Dr
MěstoGOLETA
PSČ93117-5550
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 055 620 500
Fax13026365454

Business Summary: Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.
Financial Summary: BRIEF: For the three months ended 31 March 2018, Inogen Inc revenues increased 51% to $79.1M. Net income increased 81% to $10.8M. Revenues reflect Sales revenue increase of 60% to $73.6M. Net income benefited from Interest Income increase from $101K to $543K (income), Other income increase from $207K to $444K (income). Basic Earnings per Share excluding Extraordinary Items increased from $0.29 to $0.51.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
SICElectromedical Equipment
SICSurgical And Medical Instruments



  • Poslední aktualizace: 19.6.2018
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardHeath Lukatch501.1.2008
President, Chief Executive Officer, DirectorScott Wilkinson521.3.20171.1.2008
Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate TreasurerAlison Bauerlein35
Executive Vice President of Sales and MarketingByron Myers371.1.20171.1.2011
Executive Vice President - OperationsMatthew Scribner49
Executive Vice President - EngineeringBrenton Taylor35